Seres Therapeutics (MCRB) Other Gross PP&E Adjustments (2016 - 2025)
Seres Therapeutics' Other Gross PP&E Adjustments history spans 11 years, with the latest figure at -$9.7 million for Q3 2025.
- For Q3 2025, Other Gross PP&E Adjustments rose 46.53% year-over-year to -$9.7 million; the TTM value through Sep 2025 reached -$9.7 million, up 46.53%, while the annual FY2024 figure was -$45.0 million, 9.33% up from the prior year.
- Other Gross PP&E Adjustments for Q3 2025 was -$9.7 million at Seres Therapeutics, up from -$11.8 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $44.5 million in Q3 2021 and bottomed at -$63.0 million in Q4 2022.
- The 5-year median for Other Gross PP&E Adjustments is -$14.0 million (2025), against an average of -$6.6 million.
- The largest annual shift saw Other Gross PP&E Adjustments plummeted 363.04% in 2022 before it soared 62.61% in 2025.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at $24.0 million in 2021, then tumbled by 363.04% to -$63.0 million in 2022, then increased by 21.24% to -$49.6 million in 2023, then increased by 9.33% to -$45.0 million in 2024, then surged by 78.41% to -$9.7 million in 2025.
- Per Business Quant, the three most recent readings for MCRB's Other Gross PP&E Adjustments are -$9.7 million (Q3 2025), -$11.8 million (Q2 2025), and -$14.0 million (Q1 2025).